Actuate Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Nov '25 Nov 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	137	155	-	-
Enterprise Value	120	142	-	-
Last Close Price	5.91	7.96	-	-
PB Ratio	12.56	1492.25	-	-
P/TBV Ratio	12.56	1492.25	-	-
Quick Ratio	2.66	0.98	0.43	4.71
Current Ratio	2.74	1.05	0.43	4.71
Return on Equity (ROE)	-296.04%	-	-442.40%	-
Return on Assets (ROA)	-95.25%	-255.41%	-132.96%	-
Return on Capital (ROIC)	-186.91%	-	-279.06%	-
Return on Capital Employed (ROCE)	-214.80%	-4876.60%	636.30%	-125.20%
Earnings Yield	-17.56%	-17.55%	-	-
Buyback Yield / Dilution	-418.68%	-483.48%	-18.54%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q